Professional Documents
Culture Documents
43 Paper Rudi&Krida-ICMEST2022
43 Paper Rudi&Krida-ICMEST2022
Abstract
This study aims to determine the financial performance of PT Kalbe Farma Tbk. in 2017 to 2021, namely by
analyzing ratios in the form of profitability ratios whose indicators are Net Profit Margin, liquidity ratios using
Current Ratio, and activity ratios using Total Asset Turnover. This type of research is qualitative research with
analytical methods through the stages of secondary documents, namely obtaining data from the company's financial
statements. The results show that the profitability ratio using the Net Profit Margin fluctuates, although it tends to
increase but is still below the industry standard where the average Net Profit Margin obtained in 2017-2021 is
11.92% and the industry standard is 20%. And the liquidity ratio using the Current Ratio has results that show very
healthy financial performance, the average Current Ratio in 2012-2021 is above the industry standard of 441% or
4.41 times where the industry standard is 200% or 2 times. The results of the activity ratio research using Total
Asset Turnover show an average result that is not good, which has an average yield of 1.10 times with the industry
standard 2 times. Thus, the financial performance of PT Kalbe Farma Tbk. the 2017-2021 period seen from the
profitability ratio using Net Profit Margin and the activity ratio using Total Asset Turnover, both of which are said
to be in poor financial performance. Meanwhile, the financial performance of PT Kalbe Farma Tbk. seen from the
liquidity ratio using the Current Ratio is said to be in good condition.
Keywords: Financial Performance, Net Profit Margin (NPM), Current Ratio (CR), Total Asset Turnover (TATO)
1. Introduction
The rapidly growing business world in the era of globalization and the increasing number of new companies. So that
makes companies to be more effective in running the wheels of the company's organization. The development of
globalization that occurs in Indonesia has had a profound impact on the business world. This causes competition
between companies to become increasingly fierce, many companies are no longer able to survive and also
experience sudden collapse.
Therefore, in order for a company to survive with a competitive advantage that will distinguish it from other
companies and of course a superior company is always evaluating and also able to observe the economic condition
and financial performance of the company. One company that is still surviving and even growing in the midst of
today's intense competition is PT Kalbe Farma Tbk. Currently, PT Kalbe Farma Tbk. is one of the main
pharmaceutical companies in Indonesia which is engaged in medicinal products, energy drinks, and nutrition. And
PT Kalbe Farma Tbk. it is considered the largest provincial pharmaceutical company in Southeast Asia whose shares
have been listed on the stock exchange. Pharmaceutical companies listed on the Indonesia Stock Exchange (IDX)
make this a huge opportunity for growth.
One of the information used in general in a company is financial statement information, the company is obliged to
provide financial statement information which is very important to see the movement of the progress of a company.
The financial statements used for the company are to report the situation to the owner of the company or the
employees of a company. Financial performance has a very important meaning for the company.
To see whether a company is healthy or not, it can not only be judged from its physical condition, for example, seen
from the building, construction or expansion. The most important factor to be able to see the development of a
company lies in its financial elements, because from these elements it can also evaluate whether the policies taken
by a company are appropriate or not, considering the complexity of the problems that have led to bankruptcy due to
the number of companies that eventually went out of business due to financial factors that led to bankruptcy. not
healthy. With the current situation where intense competition in the economy has begun to enter the country of
Indonesia, so if a manager does not pay attention to the financial health factor in his company, the company will go
bankrupt.
The performance of a company is the result that must be achieved from a series of processes at the expense of all the
resources of the company. The company can be said to be healthy if the company can survive in any kind of
economic condition, which can be seen from its ability to fulfill financial financial obligations and can continue to
carry out operational activities and develop its business.
Financial statement analysis requires raw materials in the form of financial statements from related companies. The
following is a description of the company's financial data PT Kalbe Farma Tbk. for the 2017-2021 period in the
form of tables used to analyze financial statements:
Table 1.1
Net Profit, Sales, and Total Assets of PT Kalbe Farma Tbk 2017-2021 Period
Year Net Profit Sales Total Assets
2017 2.453.251.410.604 20.182.120.166.616 16.616.239.416.335
2018 2.497.261.964.757 21.074.306.186.027 18.146.206.145.369
2019 2.537.601.823.645 22.633.476.361.038 20.264.726.862.584
2020 2.799.622.515.814 23.112.654.991.224 22.564.300.317.374
2021 3.232.007.683.281 26.261.194.512.313 25.666.635.156.271
Source: Annual Report of PT Kalbe Farma Tbk. period 2017-2021 (data processed 2022)
From table 1.1, it can be seen from 2017-2021 the total Net Profit of PT Kalbe Farma Tbk. tends to rise. In 2017,
2018, 2019, 2020, and 2021 experienced a movement for five years. In 2017 the total net profit was IDR
2,453,251,410,604. And experienced a slight increase in 2018, amounting to Rp. 2,497,261,964,757. In 2019 it
increased by Rp 2,537,601,823,645. In 2020, it continued to experience a significant increase of Rp.
2,799,622,515,814. Until 2021, there will be a fairly large increase reaching Rp. 3,232,007,683,281.
From table 1.1, it can be seen from 2017-2021 Sales of PT Kalbe Farma Tbk. experienced a five-year movement
from 2017 to 2021, with the lowest year in 2017 amounting to Rp 20,182,120,166,616 and the highest figure in 2021
amounting to Rp 26,261,194,512,313. PT Kalbe Farma Tbk. experienced a considerable increase from previous
years, this shows that the company has good sales value to carry out this business better in the long term.
From table 1.1 it can be seen that from 2017-2021 Total Assets of PT Kalbe Farma Tbk. has increased every year.
With the lowest year in 2017 of Rp. 16,616,239,416,335. And until 2021 it continues to experience a significant
increase of Rp. 25,666,635,156,271.
Table 1.2
Current Assets and Current Payables of PT Kalbe Farma Tbk Period 2017-2021
Year Current Assets Current Payables
2017 10.043.950.500.578 2.227.336.011.715
2018 10.648.288.386.726 2.286.167.471.594
2019 11.222.490.978.401 2.577.108.805.851
2020 13.075.331.880.715 3.176.726.211.674
2021 15.712.209.507.638 3.534.656.089.431
Source: Annual Report of PT Kalbe Farma Tbk. period 2017-2021 (data processed 2022)
Based on table 1.2, it can be seen from 2017-2021 the total Current Assets of PT Kalbe Farma Tbk. has always
experienced movement for five years from 2017 to 2021 with the lowest year being 2017 with a total of IDR
10,043,950,500,578. And the highest number in 2021 is IDR 15,712,209,507,638. PT Kalbe Farma Tbk.
experienced a fairly large increase from the previous year this was possible because the number of sales experienced
a fairly large change compared to previous years. From table 1.2, it can be seen from 2017-2021 the total Current
Debt of PT Kalbe Farma Tbk. is tending to increase. From 2017 to 2021, there was an increase in current debt for
five years. In 2017 there was an increase of IDR 2,227,336,011,715. And it continues to increase until 2021, which
is Rp. 3,534,656,089,431. Based on this description, the authors are interested in conducting research on financial
statement analysis to assess financial performance using profitability ratios, one of which is Net Profit Margin
(NPM), liquidity ratios using Current Ratio (CR), and activity ratios using Total Assets Turnover. (TATO) with the
title “Analysis of Net Profit Margin (NPM), Current Ratio (CR), and Total Assets Turnover (TATO) to Assess
the Financial Performance of PT Kalbe Farma Tbk. 2017-2021 period".
1.1 Objectives
The objectives of this research are as follows:
1. To find out the financial performance of PT Kalbe Farma Tbk. based on industry standards on Net Profit
Margin (NPM) for 2017-2021.
2. To determine the financial performance of PT Kalbe Farma Tbk. based on industry standards on the Current
Ratio (CR) in 2017-2021.
3. To determine the financial performance of PT Kalbe Farma Tbk. based on industry standards in Total Assets
Turnover (TATO) for 2017-2021.
4. To determine the financial performance of PT Kalbe Farma Tbk. in 2017-2021 based on the industry standard
soundness level seen from the analysis of Net Profit Margin, Current Ratio, and Total Assets Turnover.
2. Literature Review
2.1 Signaling Theory
Signaling theory (Signaling Theory) Signaling theory emphasizes the importance of information issued by the
company to the investment decisions of parties outside the company. Signal theory states that good quality
companies will intentionally give signals to the market, thus the market is expected to be able to distinguish good
and bad quality companies (Sugiyanto, et al., 2017) stating that companies that go public will have an obligation to
submit reports. quality finance. If the signal is positive, the market reacts thereby increasing the stock price which in
turn affects the company's performance. Furthermore, the increase in stock value reflects an increase in the
company's performance, in this case stock returns, returns on equity and earnings per share will increase. Signal
theory can also help the company (agent), owner (principal), and parties outside the company reduce information
asymmetry by producing quality or integrity of financial statement information. To ensure that interested parties
believe in the reliability of financial information submitted by the company (agent), it is necessary to obtain
opinions from other parties who are free to provide opinions on financial statements (Sugiyanto and Etty 2018).
3. Methods
This study uses a qualitative method. Researchers perform analysis with ratio formulas according to the needs of
researchers, using some of the data needed from financial statements. According to Sugiyono (2019:363) "In
qualitative research, findings or data can be declared valid if there is no difference between what the researcher
reports and what actually happened to the object being studied." The technique of checking the validity of the data
used in this study uses 2 (two) techniques, namely increasing persistence and triangulation.
Preparation in the qualitative method is carried out through the following steps:
1. Financial statements of PT Kalbe Farma Tbk obtained from the Indonesia Stock Exchange which
contain balance sheets, income statements, changes in capital reports, cash flow statements for the
period 2017-2021.
2. Analyze financial statements using financial ratios. In this study, the authors analyze the ratio
formulas according to the needs of the author, using some of the data needed from the financial
statements. Among them are profitability ratios, liquidity ratios, and activity ratios.
Table 4.1
Net Profit Margin Data for 2017-2021 PT Kalbe Farma Tbk.
Net Profit
Year Net Profit Sales Ups/Down
Margin
2017 2.453.251.410.604 20.182.120.166.616 12,15% -
2018 2.497.261.964.757 21.074.306.186.027 11,84% -0,31%
2019 2.537.601.823.645 22.633.476.361.038 11,21% -0,63%
2020 2.799.622.515.814 23.112.654.991.224 12,11% 0,9%
2021 3.232.007.683.281 26.261.194.512.313 12,30% 0,19%
Source: Processed data (2022)
Figure 4.1
Graph of Net Profit Margin Year 2017-2021 PT Kalbe Farma Tbk.
Based on the data above, that the Net Profit Margin (NPM) or Current Ratio of PT Kalbe Farma Tbk. in 2017 to
2021 fluctuated. The Net Profit Margin value in 2017 was 12.15% and decreased in 2018 by -0.31% to 11.84%, in
2019 it decreased again by -0.63% to 11.21%. Then in 2020 and 2021, it increased by 0.9% to 12.11% and increased
by 0.19% to 12.30%. Even though it fluctuated, the increase in Net Profit Margin was greater than the decrease. The
decrease in Net Profit Margin can be seen in the income statement of PT Kalbe Farma Tbk. in 2018 and 2019 due to
the increase in cost of goods sold and other expenses, and in the following years in 2020 and 2021 the company
managed to optimize efficiency in managing cost of goods sold and other expenses. Although the cost of goods sold
also increased, it was offset by an increasing level of sales. A high Net Profit Margin indicates that the company is
pricing its products correctly and has managed to control costs well.
Figure 4.2
Current Ratio Graph for 2017-2021 PT Kalbe Farma Tbk.
Current Ratio
480.00%
460.00% 465.00%
450.00%
440.00% 444.00%
435.00%
420.00% Current Ratio
411.00%
400.00%
380.00%
2017 2018 2019 2020 2021
times and 411% or 4.11 times, this decrease occurred due to an increase in the company's total current debt. In 2021,
it will increase by 33% to 444% or 4.44 times.
Although the results of the Current Ratio fluctuate, the results of the Current Ratio of PT Kalbe Farma Tbk. still
above the industry standard ratio which according to Kasmir Current Ratio is 200% or 2 times healthy. This means
that the company has the ability to pay off its short-term obligations with its current assets. The increase in Current
Ratio was due to an increase in current assets compared to current liabilities.
Tabel 4.3
Total Asset Turnover Data for 2017-2021 PT Kalbe Farma Tbk.
Year Sales Total Assets Total Asset Turnover Ups/Down
2017 20.182.120.166.616 16.616.239.416.335 1,21 times -
2018 21.074.306.186.027 18.146.206.145.369 1,16 times -0,05
2019 22.633.476.361.038 20.264.726.862.584 1,11 times -0,05
Figure 4.3
Graph of Total Asset Turnover for 2017-2021 PT Kalbe Farma Tbk.
Based on the data above, the Total Asset Turnover of PT Kalbe Farma Tbk. from the period 2017 to 2021 has
decreased. In 2017, Total Asset Turnover was recorded at 1.21 times. In 2018 Total Asset Turnover decreased by
0.05 times compared to the previous year to 1.16 times. And the following year in 2019 experienced the same
Sumber:
decrease Datatimes,
of 0.05 diolehnamely
(2022)to 1.11 times. And in 2020 it decreased again by 0.09 times to 1.02 times. And in
2021 there will be no increase or decrease, which results are the same as the previous year, namely 1.02 times.
Decrease in Total Asset Turnover of PT Kalbe Farma Tbk. This occurs because the company has not been effective
enough in using all assets to increase sales. However, when viewed from the financial statements of PT Kalbe Farma
Tbk. for the last five years, the condition of Total Asset Turnover is still quite good because every year there is an
increase in sales.
After analyzing the financial ratio data of PT Kalbe Farma Tbk. it can be seen that the financial performance of PT
Kalbe Farma Tbk. based on industry standard ratios is as follows:
4.4 Financial performance of PT Kalbe Farma Tbk. measured using Net Profit Margin (NPM)
Table 4.4
Financial Performance Assessment Net Profit Margin 2017-2021 PT Kalbe Farma Tbk.
Year Net Profit Margin Industry Standard Ratio Interval Performance
2017 12,15% 20% < 20% Unwell
2018 11,84% 20% < 20% Unwell
2019 11,21% 20% < 20% Unwell
2020 12,11% 20% < 20% Unwell
2021 12,30% 20% < 20% Unwell
Average 11,92% 20% < 20% Unwell
Source: Processed data (2022)
Net Profit Margin (NPM) or net profit margin of PT Kalbe Farma Tbk. in 2017 to 2021 fluctuated. The Net Profit
Margin value in 2017 was 12.15% and decreased in 2018 by -0.31% to 11.84%, in 2019 it decreased again by -
0.63% to 11.21%. Then in 2020 and 2021, it increased by 0.9% to 12.11% and increased by 0.19% to 12.30%.
Based on the data obtained for the last 5 years, it can be concluded that the results of the Net Profit Margin of PT
Kalbe Farma Tbk. is fluctuating. And it can be seen the results of the average Net Profit Margin that its financial
performance based on industry standards is 11.92%, which means it is still below the industry standard ratio that has
been set, which is 20%.
4.5 Financial performance of PT Kalbe Farma Tbk. measured by using the Current Ratio (CR)
Table 4.5
Current Ratio Financial Performance Assessment 2017-2021 PT Kalbe Farma Tbk.
Year Current Ratio Industry Standard Ratio Interval Performance
450% 200% >200%
2017 So healthy
(4,50 times) (2 times) (2 times)
465% 200% >200% So healthy
2018
(4,65 times) (2 times) (2 times)
435% 200% >200% So healthy
2019
(4,35 times) (2 times) (2 times)
411% 200% >200% So healthy
2020
(4,11 times) (2 times) (2 times)
444% 200% >200% So healthy
2021
(4,44 times) (2 times) (2 times)
441% 200% >200% So healthy
Average
(4,41 times) (2 times) (2 times)
Source: Processed data (2022)
Current Ratio (CR) PT Kalbe Farma Tbk. 2017 to 2021 fluctuated. In 2017 the Current Ratio was 450% or 4.50
times, and in 2018 it increased by 15% to 465% or 4.65 times. And in 2019 to 2020 it decreased by -30% and -24%
to 435% or 4.35 times and 411% or 4.11 times, this decrease occurred due to an increase in the company's total
current debt. In 2021, it will increase by 33% to 444% or 4.44 times.
Based on the data obtained for the last 5 years, it can be concluded that the results of the Current Ratio of PT Kalbe
Farma Tbk. is fluctuating. And it can be seen from the average Current Ratio that its financial performance based on
industry standards is 441%, which means it is above the industry standard ratio that has been set, which is 200%.
4.6 Financial performance of PT Kalbe Farma Tbk. measured by using Total Asset Turnover (TATO)
Based on table 4.6 Total Asset Turnover of PT Kalbe Farma Tbk. from the period 2017 to 2021 has decreased. In
2017, Total Asset Turnover was recorded at 1.21 times. In 2018 Total Asset Turnover decreased by 0.05 times
compared to the previous year to 1.16 times. And the following year in 2019 experienced the same decrease of 0.05
times, namely to 1.11 times. And in 2020 it decreased again by 0.09 times to 1.02 times. And in 2021 there will be
no increase or decrease, which results are the same as the previous year, namely 1.02 times.
Based on the data obtained for the last 5 years, it can be concluded that the results of Total Asset Turnover of PT
Kalbe Farma Tbk. is decreasing. And it can be seen the results of the average Total Asset Turnover that the financial
performance based on industry standards is 1.10 times, which means that it is below the industry standard ratio that
has been set, which is 2 times.
Table 4.6
Financial Performance Assessment Total Asset Turnover Year 2017-2021 PT Kalbe Farma Tbk.
Year Total Asset Turnover Industry Standard Ratio Interval Performance
2017 1,21 times 2 times < 2 times Unwell
2018 1,16 times 2 times < 2 times Unwell
2019 1,11 times 2 times < 2 times Unwell
2020 1,02 times 2 times < 2 times Unwell
2021 1,02 times 2 times < 2 times Unwell
Average 1,10 times 2 times < 2 times Unwell
Source: Processed data (2022)
6. Conclusion
Based on the results of research and discussion in research regarding the analysis of Net Profit Margin, Current
Ratio, and Total Asset Turnover, the authors draw several conclusions in accordance with the formulation of the
problem in this study, namely:
1. The results of the measurement of profitability ratios using the ratio of Net Profit Margin (NPM) or the net
profit margin of PT Kalbe Farma Tbk. the 2017-2021 period is said to be unfavorable even though it fluctuates
or has increased and decreased because the results continue to be below industry standards.
2. The results of the measurement of the liquidity ratio using the Current Ratio (CR) or current ratio of PT Kalbe
Farma Tbk. the 2017-2021 period experienced increases and decreases or fluctuates, but the results are said to
be very good because they are above industry standards.
3. The results of the measurement of the activity ratio using the Total Asset Turnover (TATO) ratio or the asset
turnover of PT Kalbe Farma Tbk. the 2017-2021 period is said to be unfavorable because the results have-
decreased and the results are still below industry standards.
4. Financial performance of PT Kalbe Farma Tbk. the 2017-2021 period seen from the profitability ratio using Net
Profit Margin and the activity ratio using Total Asset Turnover, both of which are said to be in poor financial
performance. Meanwhile, the financial performance of PT Kalbe Farma Tbk. seen from the liquidity ratio using
the Current Ratio is said to be in good condition.
References
Fahmi, I., Analisis Kinerja Keuangan Panduan bagi Akademisi, Manajer, dan Investor untuk Menilai dan
Menganalisis Bisnis dari Aspek Keuangan, Bandung: CV. Alfabeta, 2017.
Hasyim, M. A. N., & Nuraeni, Y. A., Analysis Of The Effect Of Current Ratio, Total Asset Turnover, Debt To
Equity Ratio, Net Profit Margin Toward Retrun on Equity, Technology Management, 1(1), 1-15, 2022.
Irman, M., & Purwati, A. A., Analysis on the influence of current ratio, debt to equity ratio and total asset turnover
toward return on assets on the otomotive and component company that has been registered in Indonesia Stock
Exchange Within 2011-2017, International Journal of Economics Development Research (IJEDR), 1(1), 36-44,
2020.
Kasmir, Pengantar Manajemen Keuangan Edisi Kedua, Jakarta: Prenadamedia Group, 2018.
Maisharoh, T., & Riyanto, S., Financial Statements Analysis in Measuring Financial Performance of the PT. Mayora
Indah Tbk, Period 2014-2018, Journal of Contemporary Information Technology, Management, and
Accounting, 1(2), 63-71, 2020.
Munawir, S, Analisa Laporan Keuangan Edisi Keempat, Yogyakarta: Liberty Yogyakarta, 2014.
Rahayu, K. P., & Sanjaya, R., Pengaruh Loan to Deposit Ratio dan Beban Operational Per Pendapatan Operasional
Terhadap Return on Asset Pada PT. Bank Mega Tbk Yang Tercatat Di Bursa Efek Indonesia (BEI), RJABM
(Research Journal of Accounting and Business Management), 5(2), 138-153, 2022.
Rhamadana, R. B., & Triyonowati, T., Analisis rasio keuangan untuk menilai kinerja keuangan pada PT. HM
Sampoerna Tbk., Jurnal Ilmu Dan Riset Manajemen (JIRM), 2461-0593, 2016.
Sanjaya, R., Pengaruh Faktor Fundamental Terhadap Dividend Payout Ratio Serta Dampaknya Terhadap Price
Earning Ratio Pada Perusahaan Perkebunan Kelapa Sawit Yang Terdaftar Di Bursa Malaysia, Jurnal
SEKURITAS (Saham, Ekonomi, Keuangan dan Investasi), 5(1), 75-84, 2021.
Sanjaya, R., The Impact of Source and Use of Funds on Liquidity at PT. Mustika Ratu Tbk., Jurnal SEKURITAS
(Saham, Ekonomi, Keuangan dan Investasi), 3(2), 158-165, 2020.
Sanjaya, R., The Influence of Ratio Analysis to The Dividend Payout Ratio and Its Impact on The Value of The
Company Listed On The Malaysia Stock Exchange, Economic & Accounting Journal, 2(2), 95-103, 2019.
Sanjaya, R., & Lativa, L., Pengaruh Pengendalian Internal, Penerapan Standar Akuntansi Keuangan (SAK), Dan
Bukti-Bukti (Kecukupan dan Kelayakan) Audit Terhadap Opini Laporan Keuangan Wajar Tanpa Pengecualian
“Studi Penelitian Di Kantor Akuntan Publik Di Jakarta Selatan, RJABM (Research Journal of Accounting and
Business Management), 5(2), 171-185, 2022.
Sanjaya, R., & Rahayu, K. P., The Influence of Fundamental Factors of Macroeconomics Against Price Earning
Ratio through Dividend Payout Ratio for LQ. 45 Non-Banking Companies, Jurnal SEKURITAS (Saham,
Ekonomi, Keuangan dan Investasi), 4(1), 80-95, 2020.
Sugiyono, Metode Penelitian Kuantitatif, Kualitatif, dan R&D, Bandung: Alfabeta, Sugiyono.
Biography / Biographies
Rudi Sanjaya is a lecturer at the Faculty of Economics and Business, Pamulang University,
Indonesia. He holds a Masters in Management with a concentration in Financial Management
from the Faculty of Economics, Pamulang University, in 2017. He has worked as a lecturer at the
Faculty of Economics and Business (FEB), Pamulang University since 2017. His fields of study
are Financial Management, Financial Statement Analysis, Budgeting. Introduction of accounting.
Krida Puji Rahayu is a lecturer who obtained a master's degree from the Malang state
university since 2015. Research interests in statistics and economic mathematics.